UnknownNot Applicable

Treatment of Post-covid Syndrome in Patients Treated in Intensive Care

Sweden40 participantsStarted 2021-11-01

Plain-language summary

The present study is a pilot randomized controlled trial, which identifies and diagnoses mental health problems in survivors of critical COVID-19 infection at 12 months post-ICU care, and randomize patients to either an ACT-enforced CBT intervention, or to treatment as usual.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * COVID-19 survivors who screen positive for clinical anxiety or depression, defined as reaching a score of ≥ 8 on either the anxiety or depression sub-scales within the questionnaire HADS at the standard 12-months follow-up Exclusion Criteria: * Conditions in which patients are acutely suicidal, psychotic, suffering from a mental disorder requiring in-patient psychiatric treatment, opposed to receiving a psycho-therapeutic intervention, or with cognitive problems or language difficulties which are judged to be too extensive for the informed consent procedure and for a psycho-therapeutic intervention

What they're measuring

Feasibility with respect to willingness for treatment study inclusion

Timeframe: 8 weeks post-assessment

Feasibility with respect to patient adherence

Timeframe: 2 weeks post-treatment

Patient satisfaction with therapy intervention

Timeframe: 2 weeks post-treatment

Trial details

NCT IDNCT05119608

SponsorRegion Skane

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-09-30

Contact for this trial

Anders Håkansson, PhD

+46 46 175596 anders_c.hakansson@med.lu.se

View on ClinicalTrials.gov More COVID-19 trials